Quantum Biosystems has raised 2.4 billion yen to accelerate the company’s DNA/RNA sequencer development as of February 6th. This Series B funding is from two new investors, Innovation Network Corporation of Japan(INCJ) and Mitsubishi UFJ Capital(MUCAP), and three existing investors, JAFCO, UTEC and Mizuho Capital.
For the article, please look at the following.
LINK: Quantum Biosystems News

Quantum Biosystems is pioneering the development of innovative sequencers based on quantum mechanics. Its proprietary Quantum Sequencing[TM] technology achieves single molecule electrical DNA sequencing by integrating cutting edge silicon technology and a sophisticated electric detection system into breakthrough approaches to life sciences. This platform allows disruptively label-free, low-cost, high-throughput, and real-time analysis with no need for complex sample preparation, detection, or analysis.
LINK: Quantum Biosystems Company Profile